These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2697156)

  • 21. The prophylaxis of malignant hyperthermia by oral dantrolene sodium in swine.
    Harrison GG
    Br J Anaesth; 1977 Apr; 49(4):315-7. PubMed ID: 889645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of muscle relaxants on masseter tone. An experimental study in an MH-susceptible swine model].
    Jantzen JP; Eberle B; Gaida BJ; Hennes HJ; Otto S; Schäfer M
    Anaesthesist; 1992; 41(5):248-53. PubMed ID: 1616114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dantrolene dose response in malignant hyperthermia-susceptible (MHS) swine: method to obtain prophylaxis and therapeusis.
    Flewellen EH; Nelson TE
    Anesthesiology; 1980 Apr; 52(4):303-8. PubMed ID: 7362049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dantrolene in porcine malignant hyperthermia.
    Gronert GA; Milde JH; Theye RA
    Anesthesiology; 1976 Jun; 44(6):488-95. PubMed ID: 1275316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anesthesia for elective surgery in patients susceptible to malignant hyperthermia.
    Relton JE
    Int Anesthesiol Clin; 1979; 17(4):141-51. PubMed ID: 521179
    [No Abstract]   [Full Text] [Related]  

  • 26. Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
    Bronstein SL; Ryan DE; Solomons CC; Mahowald MC
    J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Caesarean section in a patient with past history of fulminant malignant hyperthermia].
    Goto S; Ogata K; Fujie T; Fujigaki T; Nakamura H; Yukinari T; Shibata O
    Masui; 1993 Feb; 42(2):271-5. PubMed ID: 8437362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of 119 anaesthetics received after investigation for susceptibility to malignant hyperthermia.
    Ording H; Hedengran AM; Skovgaard LT
    Acta Anaesthesiol Scand; 1991 Nov; 35(8):711-6. PubMed ID: 1763590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [An attempt to reconcile differences of opinion in the field of malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):464-7. PubMed ID: 1786307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do we foresee new emerging drugs to treat malignant hyperthermia?
    Just KS; Gerbershagen MU; Grensemann J; Wappler F
    Expert Opin Emerg Drugs; 2015 Jun; 20(2):161-4. PubMed ID: 25736705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurosurgery in the malignant hyperthermia-susceptible patient.
    Wackym PA; Dubrow TJ; Abdul-Rasool IH; Peacock WJ
    Neurosurgery; 1988 Jun; 22(6 Pt 1):1032-6. PubMed ID: 3419564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal block, after dantrolene pretreatment, for resection of a thigh muscle herniation in a young malignant hyperthermia susceptible man.
    Oikkonen M; Rosenberg PH; Björkenheim JM; Paetau A; Huopaniemi T
    Acta Anaesthesiol Scand; 1987 May; 31(4):309-11. PubMed ID: 3591254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine ("ecstasy").
    Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Menge M; Schulte Am Esch J
    Anesthesiology; 2003 Nov; 99(5):1132-6. PubMed ID: 14576550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anesthesiologic management of susceptible children at risk for malignant hyperthermia].
    Ferrari F; D'Alessandro S; Pietrandrea G; Villani A
    Minerva Anestesiol; 1997 Oct; 63(10):311-4. PubMed ID: 9567608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Verapamil is not a therapeutic adjunct to dantrolene in porcine malignant hyperthermia.
    Gallant EM; Foldes FF; Rempel WE; Gronert GA
    Anesth Analg; 1985 Jun; 64(6):601-6. PubMed ID: 4003778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Malignant hyperthermia].
    Schulte-Sasse U; Eberlein HJ
    Anaesthesist; 1983 Apr; 32(4):141-57. PubMed ID: 6349413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The screening of propofol in MHS swine.
    Raff M; Harrison GG
    Anesth Analg; 1989 Jun; 68(6):750-1. PubMed ID: 2786680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant hyperthermia in Mazovia Province - are we adequately prepared?
    Cieniewicz A; Trzebicki J
    Anaesthesiol Intensive Ther; 2022; 54(2):99-102. PubMed ID: 35579281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical features of malignant hyperthermia crisis].
    Cornet C; Moeller R; Laxenaire MC
    Ann Fr Anesth Reanim; 1989; 8(5):435-43. PubMed ID: 2516711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Registration of peranesthetic cases of malignant hyperthermia in France. An update].
    Jacquot C; Stieglitz P; Kozak-Reiss G; Krivosic-Horber R; Laxenaire MC; Lienhart A; Nivoche Y
    Ann Fr Anesth Reanim; 1988; 7(6):524-34. PubMed ID: 3223647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.